Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

 

Tiziana Life Sciences plc (LSE: TILS) (the "Company") announces that on 20 August 2018, Dr Shailubhai Kunwar, Chief Executive Officer and Tiziano Lazzaretti, Chief Financial Officer bought  shares in the Company as follows :

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 

1.	Details  of PDMR / person closely associated
a)	Name	Dr Shailubhai Kunwar
2.	Reason for the notification: On market acquisition
a)	Position / status	Chief Executive Officer
b)	Initial notification /amendment	Initial notification
3.	Details of the issuer
a)	Name	Tiziana Life Sciences plc
b)	LEI	213800CED47HI8PIOB36
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type  of transaction; (iii) each date; and (iv) each place where transactions have  been conducted
a)	Description of the financial instrument	Ordinary Shares of 3p each
b)	Identification code of the Financial Instrument	ISIN for Tiziana Life Sciences plc: GB00BKWNZY55
c)	Nature of the transaction	Acquisition of shares
d)	Price(s) and volume(s)	Price: £1.01; Volume: 5,000
e)	Aggregated information -     Aggregated volume -     Price	5,000  £5,050
f)	Date of the transaction	20 August 2018
g)	Place of the transaction	XLON

 

1.	Details  of PDMR / person closely associated
a)	Name	Tiziano Lazzaretti
2.	Reason for the notification: On market acquisition
a)	Position / status	Chief Financial Officer
b)	Initial notification /amendment	Initial notification
3.	Details of the issuer
a)	Name	Tiziana Life Sciences plc
b)	LEI	213800CED47HI8PIOB36
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type  of transaction; (iii) each date; and (iv) each place where transactions have  been conducted
a)	Description of the financial instrument	Ordinary Shares of 3p each
b)	Identification code of the Financial Instrument	ISIN for Tiziana Life Sciences plc: GB00BKWNZY55
c)	Nature of the transaction	Acquisition of shares
d)	Price(s) and volume(s)	Price: £0.80; Volume: 2,000
e)	Aggregated information -     Aggregated volume -     Price	2,000  £1,625
f)	Date of the transaction	20 August 2018
g)	Place of the transaction	XLON

 

Neither Dr Shailubhai nor Mr Lazzaretti were holders of shares in the Company prior to the acquisitions set out above.

For more information go to http://www.tizianalifesciences.com

 

Contacts:

Tiziana Life Sciences plc Gabriele Cerrone, Chairman and founder	+44 (0)20 7493 2853
Cairn Financial Advisers LLP (Nominated adviser) Liam Murray / Jo Turner	+44 (0)20 7213 0883
Stockdale Securities (Broker) Antonio Bossi / Andy Crossley	+44 (0)20 7601 6100